XML 100 R29.htm IDEA: XBRL DOCUMENT
v3.26.1

NET INCOME (LOSS) PER SHARE (Tables) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2026 | Dec. 31, 2025
Earnings Per Share [Abstract] |  |
Schedule of Earnings Per Share, Basic and Diluted | The following table summarizes the Company’s computation of basic and diluted net income (loss) per share available to common stockholders for the three months ended March 31, 2026 and 2025:
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Three Months Ended March 31,
​ | ​ | 2026 | ​ ​ ​ | 2025
Numerator: |  | ​ | ​ |  | ​ | ​
Net income (loss) | ​ | $ | 5,686 | ​ | $ | (5,688)
Less: Earnings allocated to participating securities | ​ |  | ​ | ​ |  | ​
Accumulated undeclared dividends – Series A | ​ |  | (2,664) | ​ |  | —
Accumulated undeclared dividends – Series B | ​ |  | (2,283) | ​ |  | —
Allocable net income (loss) | ​ |  | 739 | ​ |  | (5,688)
Allocation of undistributed earnings – Series A | ​ |  | (199) | ​ |  | —
Allocation of undistributed earnings – Series B | ​ |  | (185) | ​ |  | —
Net income (loss) available to common stockholders | ​ | $ | 355 | ​ | $ | (5,688)
Denominator: | ​ |  | ​ | ​ |  | ​
Weighted average common shares outstanding – basic and diluted | ​ |  | 5,455 | ​ |  | 4,618
Net income (loss) per common share available to common stockholders – basic and diluted | ​ | $ | 0.07 | ​ | $ | (1.23)
| The following tables summarizes the Company’s computation of basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2025 and 2024:
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
​ | ​ ​ ​ | 2025 | ​ ​ ​ | 2024
Numerator: | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) | ​ | $ | 1,365 | ​ | $ | (25,915)
Accumulated undeclared dividends on series A preferred stock | ​ |  | (1,035) | ​ |  | —
Accumulated undeclared dividends on series B preferred stock | ​ |  | (887) | ​ |  | —
Net loss attributable to common stockholders | ​ | $ | (557) | ​ | $ | (25,915)
Denominator: | ​ |  | ​ | ​ |  | ​
Weighted average common shares outstanding | ​ |  | ​ | ​ |  | ​
– basic and diluted | ​ |  | 5,027 | ​ |  | 4,347
Net loss per share attributable to common stockholders | ​ |  | ​ | ​ |  | ​
– basic and diluted | ​ | $ | (0.11) | ​ | $ | (5.96)
Schedule of Antidilutive Securities | The following table summarizes potential common shares outstanding at each period end that were excluded from diluted net income (loss) per share because their effect would have been anti-dilutive:
​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Three Months Ended March 31,
​ | ​ | 2026 | ​ ​ ​ | 2025
Public warrants |  | 500,000 |  | 500,000
Private warrants |  | 13,300 |  | 13,300
Stock options |  | 255,189 |  | 270,554
Unvested restricted stock units |  | 83,396 |  | 203,714
Shares issuable upon Series A and Series B Preferred Stock Conversion |  | 5,891,471 |  | —
Total potential common shares excluded |  | 6,743,356 |  | 987,568
​ | The following table summarizes potential common shares outstanding at each period end that were excluded from diluted net loss per share because their effect would have been anti-dilutive:
​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
​ | ​ | 2025 | ​ | 2024
Public warrants | ​ ​ ​ | 500,000 | ​ ​ ​ | 500,000
Private warrants |  | 13,300 |  | 13,300
Stock options |  | 255,189 |  | 270,554
Unvested restricted stock units |  | 115,758 |  | 264,812
Shares issuable upon Series A and Series B Preferred Stock Conversion |  | 5,636,650 |  | —
Total common stock equivalents |  | 6,520,897 |  | 1,048,666
​

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration